New research by BAT indicates that modern oral products (MOPs), namely nicotine pouches , showed lower toxicity responses in certain assays than traditional cigarettes.
Scientists analyzed the toxicological impact of one of BAT's nicotine pouch products, formerly called Lyft and now known as Velo , in an in vitro laboratory-based test. Velo was compared with a reference cigarette (1R6F) and reference Swedish-style snus pouch (CRP1.1).
Velo was found to be less biologically active than cigarette smoke and snus, even at greater concentrations of nicotine, across a range of tests. In many cases, Velo failed to elicit a biological response at all, supporting the view that MOPs are likely to be less risky than traditional cigarettes and Swedish-style snus for users who switch completely.
Pre-clinical scientist Emma Cheung, who led the study, said the results added to the growing body of evidence to support the reduced-risk potential of MOPs compared to continuing to smoke.
Velo was found to be less biologically active than cigarette smoke in certain assays, which is very encouraging. We are committed to building a better tomorrow by reducing the health impact of our business through offering a greater choice of products for our consumers, and this study helps to support the reduced-risk potential of MOPs. Our scientists will continue to build evidence to support our New Category products."
Emma Cheung, Study Lead Author and Pre-clinical Scientist,
The results have been published in Food and Chemical Toxicology .
For more great articles please check here: NICFORMATION - nicotine pouch news and articles
ความคิดเห็น
แสดงความคิดเห็น